Aifm3-flox Mouse
一般名
Aifm3-flox
製品ID
S-CKO-15384
背景情報
C57BL/6JCya
系統ID
CKOCMP-72168-Aifm3-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Aifm3-flox Mouse(カタログ番号S-CKO-15384)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Aifm3-flox
系統ID
CKOCMP-72168-Aifm3-B6J-VA
遺伝子名
製品ID
S-CKO-15384
遺伝子別名
Aifl, 2810401C16Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 16
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000023448
NCBIトランスクリプトID
NM_175178
ターゲット領域
Exon 4~9
有効領域の大きさ
~2.0 kb
遺伝子研究の概要
Aifm3, also known as apoptosis-inducing factor, mitochondrion-associated 3, is a protein-coding gene. It has been implicated in multiple biological functions. In kidney development, it is considered important for promoting cell survival, energy production in nephrogenesis, and tubular maturation [2]. In the context of neural development, it is involved in the metabolic reprogramming regulated by GSDMD, which links pyroptosis to metabolic changes during cortical development [3].
In mice, two subsets of cholinergic neurons in the medial septum are segregated based on the expression of Aifm3 among other marker genes. These subpopulations have unique electrophysiological signatures, make differential connections in the hippocampus, and play different roles in anxiety-like behavior and spatial memory [1].
In cancer research, Aifm3 is over-expressed in cholangiocarcinoma (CCA), and its serum levels can serve as a prognostic biomarker. Silencing Aifm3 in CCA cells significantly decreases cell migration and invasion, suggesting its role in CCA metastasis [4]. It is also over-expressed in breast cancer, associated with tumor size, lymph node metastasis, TNM stage, and shorter survival [5]. In medullary thyroid carcinoma, recurrent copy number gains of Aifm3 are found, and its expression is confirmed in tumor cases but not in normal thyroid tissues [6].
In conclusion, Aifm3 plays crucial roles in normal development processes such as kidney and neural development. In disease, especially in multiple types of cancers, Aifm3 shows abnormal expression patterns and is involved in tumor-related processes like metastasis and prognosis. The study of Aifm3 using mouse models and other experimental systems has provided valuable insights into its functions in both normal and disease-associated biological processes.
References:
1. Li, Xinyan, Yu, Hongyan, Zhang, Bing, Zhu, Ling-Qiang, Lu, Youming. 2022. Molecularly defined and functionally distinct cholinergic subnetworks. In Neuron, 110, 3774-3788.e7. doi:10.1016/j.neuron.2022.08.025. https://pubmed.ncbi.nlm.nih.gov/36130594/
2. Lozic, Mirela, Minarik, Luka, Racetin, Anita, Saraga Babic, Mirna, Vukojevic, Katarina. 2021. CRKL, AIFM3, AIF, BCL2, and UBASH3A during Human Kidney Development. In International journal of molecular sciences, 22, . doi:10.3390/ijms22179183. https://pubmed.ncbi.nlm.nih.gov/34502088/
3. Ma, Hongyan, Jia, Huiyang, Zou, Wenzheng, Yuan, Chenqi, Jiao, Jianwei. 2024. Gasdermin D Mediated Mitochondrial Metabolism Orchestrate Neurogenesis Through LDHA During Embryonic Development. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2402285. doi:10.1002/advs.202402285. https://pubmed.ncbi.nlm.nih.gov/39033542/
4. Chua-On, Daraporn, Proungvitaya, Tanakorn, Techasen, Anchalee, Araki, Norie, Proungvitaya, Siriporn. . Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells. In Cancer genomics & proteomics, 19, 35-49. doi:10.21873/cgp.20302. https://pubmed.ncbi.nlm.nih.gov/34949658/
5. Zheng, Ang, Zhang, Lin, Song, Xinyue, Wei, Minjie, Jin, Feng. 2019. Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients. In BMC cancer, 19, 451. doi:10.1186/s12885-019-5659-4. https://pubmed.ncbi.nlm.nih.gov/31088422/
6. Araujo, Aline Neves, Camacho, Cléber Pinto, Mendes, Thais Biude, Maciel, Rui Monteiro de Barros, Cerutti, Janete Maria. 2021. Comprehensive Assessment of Copy Number Alterations Uncovers Recurrent AIFM3 and DLK1 Copy Gain in Medullary Thyroid Carcinoma. In Cancers, 13, . doi:10.3390/cancers13020218. https://pubmed.ncbi.nlm.nih.gov/33435319/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
